Exact Mass: 668.1804
Exact Mass Matches: 668.1804
Found 15 metabolites which its exact mass value is equals to given mass value 668.1804
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Acetylpuerarin
[3,4,5-Tris(acetyloxy)-6-[7-(acetyloxy)-3-[4-(acetyloxy)phenyl]-4-oxo-4H-chromen-8-yl]oxan-2-yl]methyl acetic acid
Becatecarin
5,21-dichloro-13-[2-(diethylamino)ethyl]-3-[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione
Okanin 4-methyl ether 4-O-(2-O-caffeoyl-6-O-acetylglucoside)
3,4,2,3,4-Pentahydroxy-4-methoxychalcone 4-methyl ether 4-O- (2"-O-caffeoyl-6"-O-acetylglucoside)
4-Me ether,4-O-(6-O-acetyl-2-O-caffeoyl-beta-D-glucopyranoside)-2鈥樎嚶?脫3楼?脫3鈥樎仿?脫4楼?脫4鈥樎?Pentahydroxychalcone
4-Me ether,4-O-(6-O-acetyl-2-O-caffeoyl-beta-D-glucopyranoside)-2鈥樎嚶?脫3楼?脫3鈥樎仿?脫4楼?脫4鈥樎?Pentahydroxychalcone
Becatecarin
Becatecarin
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
[3,4,5-Triacetyloxy-6-[7-acetyloxy-3-(4-acetyloxyphenyl)-4-oxochromen-8-yl]oxan-2-yl]methyl acetate
[3,4,5-Triacetyloxy-6-[7-acetyloxy-3-(4-acetyloxyphenyl)-4-oxochromen-8-yl]oxan-2-yl]methyl acetate
3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamide
3-(4-bromophenyl)-N-[5-[[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)anilino]-oxomethyl]-2-methylphenyl]-1H-pyrazole-5-carboxamide
3,7-bis(4-hydroxy-3,5-dimethoxyphenyl)-4-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one
3,7-bis(4-hydroxy-3,5-dimethoxyphenyl)-4-[(2S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,8-dioxatricyclo[7.3.1.05,13]trideca-1(12),3,5(13),6,9-pentaen-11-one
methyl (2r)-8-{3-[3,6-dihydroxy-2-(methoxycarbonyl)-4-methylbenzoyl]-2,4-dihydroxyphenyl}-5-hydroxy-2-[(1s,2r)-1-hydroxy-4-methoxy-2-methyl-4-oxobutyl]-4-oxo-3h-1-benzopyran-2-carboxylate
methyl (2r)-8-{3-[3,6-dihydroxy-2-(methoxycarbonyl)-4-methylbenzoyl]-2,4-dihydroxyphenyl}-5-hydroxy-2-[(1s,2r)-1-hydroxy-4-methoxy-2-methyl-4-oxobutyl]-4-oxo-3h-1-benzopyran-2-carboxylate
(2s,3r,4s,5r,6s)-6-[(acetyloxy)methyl]-2-{2,3-dihydroxy-4-[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]phenoxy}-4,5-dihydroxyoxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2s,3r,4s,5r,6s)-6-[(acetyloxy)methyl]-2-{2,3-dihydroxy-4-[(2e)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoyl]phenoxy}-4,5-dihydroxyoxan-3-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methyl (2r)-6-{3-[3,6-dihydroxy-2-(methoxycarbonyl)-4-methylbenzoyl]-2,4-dihydroxyphenyl}-5-hydroxy-2-[(1s,2r)-1-hydroxy-4-methoxy-2-methyl-4-oxobutyl]-4-oxo-3h-1-benzopyran-2-carboxylate
methyl (2r)-6-{3-[3,6-dihydroxy-2-(methoxycarbonyl)-4-methylbenzoyl]-2,4-dihydroxyphenyl}-5-hydroxy-2-[(1s,2r)-1-hydroxy-4-methoxy-2-methyl-4-oxobutyl]-4-oxo-3h-1-benzopyran-2-carboxylate
[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoate
(10s)-10-{[(9s)-3-carboxy-2,5-dihydroxy-4,6,9-trimethyl-10-oxoanthracen-9-yl]peroxy}-8-hydroxy-3-methoxy-1,7,10-trimethyl-9-oxoanthracene-2-carboxylic acid
(10s)-10-{[(9s)-3-carboxy-2,5-dihydroxy-4,6,9-trimethyl-10-oxoanthracen-9-yl]peroxy}-8-hydroxy-3-methoxy-1,7,10-trimethyl-9-oxoanthracene-2-carboxylic acid